L'Italien
James J. L'Italien, Rancho Santa Fe, CA US
Patent application number | Description | Published |
---|---|---|
20080249018 | Exendin Analog Formulations - Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided | 10-09-2008 |
20090215694 | Lyophilized Formulations of Exendins and Exendin Agonist Analogs - Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided. | 08-27-2009 |
20110281798 | Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs - Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided. | 11-17-2011 |
20130165379 | Formulations of Exendins and Exendin Agonist Analogs - Provided herein are formulations containing exendins, exendin, agonists and/or exendin analogs and methods of using the exendins, exendin agonists and/or exendin analogs and formulations thereof to treat glucagonoma and necrolytic migratory erythema, or to suppress glucagon secretion. | 06-27-2013 |
James J. L'Italien, Rancho Sante Fe, CA US
Patent application number | Description | Published |
---|---|---|
20150080308 | Formulations and Uses of Exendins and Exendin Agonist Analogs - Provided herein are formulations containing exendins, exendin agonists and/or exendin analogs and methods of using the exendins, exendin agonists and/or exendin analogs and formulations thereof to treat glucagonoma and necrolytic migratory erythema, or to suppress glucagon secretion. | 03-19-2015 |
James L. L'Italien, Del Mar, CA US
Patent application number | Description | Published |
---|---|---|
20090018053 | FORMULATIONS FOR AMYLIN AGONIST PEPTIDES - The present invention is concerned with a pharmaceutical formulation comprising an amylin agonist and optionally a buffer, a tonicifier or stabilizer, and a preservative in a container, for example, a vial, prefilled cartridge, prefilled syringe or disposable pen. This formulation may be in liquid, gel, solid or powdered form for delivery, for example, via nasal, pulmonary, oral, sublingual, buccal, transdermal, or parenteral routes. Formulation with biocompatible polymers and release modifiers, such as sugars, can facilitate controlled release after injection, minimizing the number of administrations to a patient. These formulations maintain stability upon storage under refrigerated or room temperature conditions. Such formulations can be further combined with insulin for administration to a patient. | 01-15-2009 |
Reginald L'Italien, New London, NC US
Patent application number | Description | Published |
---|---|---|
20150374042 | UPPER AND LOWER TORSO GARMENTS HAVING AN IMPROVED BAND - A torso garment, such as a brassiere or brief, includes a body formed of inner and outer layers, the body including at least one torso band extending from a portion of the body, where the inner and outer layers overlap along a fold line of the torso garment. The torso garment includes an elastomeric band positioned between the inner and outer layers proximate the fold line. | 12-31-2015 |